| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Fyrwald J Erik | Director | LILLY CORPORATE CENTER, INDIANAPOLIS | /s/ Jonathan Groff for J. Erik Fyrwald, pursuant to authorization on file | 2025-08-12 | 0001343564 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LLY | Common Stock | Purchase | $440K | +686 | +0.94% | $642.00 | 73.7K | Aug 12, 2025 | Direct | F1 |
| transaction | LLY | Common Stock | Purchase | $565K | +879 | +1.19% | $642.59 | 74.6K | Aug 12, 2025 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $641.49 to $642.27 (row 1), and $642.50 to $642.97 (row 2), respectively. The reporting person undertakes to provide to Eli Lilly and Company, any security holder of Eli Lilly and Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |